Client Novavax, Maker of COVID-19 Vaccine, Signs $1.4 Billion Agreement with Sanofi

Source :: European Union News. May 13, 2024
Publication Year :: 2024
Abstract: Massachusetts: Ropes & Gray has issued the following press release: Ropes & Gray represented Novavax Inc., in a co-exclusive licensing agreement with French pharmaceutical company Sanofi to sell Novavax COVID-19 [...]

Subjects :: Novavax Inc. -- Licensing agreements
Sanofi S.A. -- Licensing agreements
Influenza vaccines -- Licensing agreements
Pharmaceutical industry -- Licensing agreements
Company licensing agreement
Business, international

Tools